Cam V. Ngo

Cutting Edge: Systemic Inhibition of Angiogenesis Underlies Resistance to Tumors During Acute Toxoplasmosis1

C. Hunter, C. Sevignani, S. Evans, 2001, The Journal of Immunology.

CNTO 859, a humanized anti‐tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models

K. Picha, S. Tam, F. McCabe, 2007, International journal of cancer.

Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.

C. Sevignani, A. Thomas-Tikhonenko, Karla D. Kenyon, 2000, Nucleic acids research.

An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.

O. Volpert, D. Yu, Duonan Yu, 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.